Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, enzymes in India, Europe, the United States, and internationally. The company engages in the pharmaceutical formulations and environmental solutions; rents and sales properties; and sports and health awareness/education activities. It offers various variants of vitamin D3, including crystalline oil, resin oil, cold water dispersible, and feed grade powder used in applications, such as pharmaceuticals, dietary and nutritional supplements, feed, injectables, soft gel capsules, premixes, food and beverage fortification, veterinary, feed and rodenticides; pharmaceutical ingredients comprising of phenyramidol and silicon dry powder; nutritional premixes; and enzymes, used in pharmaceuticals, food and fragrances, oleo, biodiesel, leather, fine chemical, bio-plastics, and cosmetic industries. In addition, the company provides engages in the design, engineering, procurement, and construction of water and wastewater treatment plants; and offers operations and maintenance services, as well as property development business. The company was formerly known as DIL Limited. Fermenta Biotech Limited was incorporated in 1951 and is based in Thane, India. Fermenta Biotech Limited operates as a subsidiary of DVK Investments Private Limited.
Metrics to compare | FERM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFERMPeersSector | |
---|---|---|---|---|
P/E Ratio | 20.2x | 18.8x | −0.5x | |
PEG Ratio | 0.07 | 0.79 | 0.00 | |
Price/Book | 2.5x | 1.6x | 2.6x | |
Price / LTM Sales | 1.7x | 1.5x | 3.0x | |
Upside (Analyst Target) | - | 36.6% | 56.6% | |
Fair Value Upside | Unlock | −9.1% | 10.1% | Unlock |